Easterly Investment Partners LLC Pfizer Inc Transaction History

Easterly Investment Partners LLC

$1.22 Billion
Q3 2024

A detailed history of Easterly Investment Partners LLC transactions in Pfizer Inc stock. As of the latest transaction made, Easterly Investment Partners LLC holds 19,300 shares of PFE stock, worth $515,696. This represents 0.05% of its overall portfolio holdings.

Number of Shares

19,300

Previous 19,300 -0.0%

Holding current value

$515,696

Previous $540,000 3.33%

% of portfolio

0.05%

Previous 0.05%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	SELL	$25.26 - $29.6 $20,536 - $24,064	-813 Reduced 4.04%	19,300 $540,000
Q1 2024 May 03, 2024	SELL	$25.89 - $29.73 $1.22 Million - $1.4 Million	-47,243 Reduced 70.14%	20,113 $558,000
Q4 2023 Feb 14, 2024	SELL	$26.13 - $33.94 $8.85 Million - $11.5 Million	-338,645 Reduced 83.41%	67,356 $1.94 Million
Q3 2023 Nov 13, 2023	BUY	$32.09 - $37.51 $41,556 - $48,575	1,295 Added 0.32%	406,001 $13.5 Million
Q2 2023 Nov 13, 2023	BUY	$36.12 - $41.79 $4.95 Million - $5.73 Million	137,180 Added 51.28%	404,706 $14.8 Million
Q1 2023 Nov 13, 2023	SELL	$39.39 - $51.28 $112,852 - $146,917	-2,865 Reduced 1.06%	267,526 $10.9 Million
Q1 2023 May 02, 2023	BUY	$39.39 - $51.28 $7.04 Million - $9.16 Million	178,712 Added 93.23%	370,400 $15.1 Million
Q4 2022 Nov 13, 2023	SELL	$41.75 - $54.5 $4.18 Million - $5.45 Million	-100,009 Reduced 27.0%	270,391 $13.9 Million
Q4 2022 Feb 10, 2023	SELL	$41.75 - $54.5 $3.84 Million - $5.02 Million	-92,037 Reduced 32.44%	191,688 $9.83 Million
Q3 2022 Nov 09, 2022	SELL	$43.76 - $53.42 $8.98 Million - $11 Million	-205,322 Reduced 41.98%	283,725 $12.4 Million
Q2 2022 Aug 10, 2022	SELL	$46.53 - $55.17 $7.79 Million - $9.24 Million	-167,487 Reduced 25.51%	489,047 $25.6 Million
Q1 2022 May 13, 2022	BUY	$45.75 - $56.69 $16 Million - $19.8 Million	349,682 Added 113.96%	656,534 $34 Million
Q4 2021 Aug 02, 2022	BUY	$41.32 - $61.25 $3.34 Million - $4.96 Million	80,928 Added 35.82%	306,852 $18.1 Million
Q4 2021 Feb 08, 2022	SELL	$41.32 - $61.25 $9.63 Million - $14.3 Million	-233,161 Reduced 50.79%	225,924 $13.3 Million
Q3 2021 Nov 16, 2021	BUY	$39.25 - $50.42 $12.4 Million - $15.9 Million	316,141 Added 221.16%	459,085 $19.7 Million
Q3 2021 Nov 01, 2021	SELL	$39.25 - $50.42 $280,088 - $359,797	-7,136 Reduced 4.75%	142,944 $6.15 Million
Q2 2021 Jul 27, 2021	SELL	$35.91 - $40.68 $8.33 Million - $9.44 Million	-231,991 Reduced 60.72%	150,080 $5.88 Million
Q2 2021 Jul 26, 2021	SELL	$35.91 - $40.68 $7.68 Million - $8.7 Million	-213,794 Reduced 35.88%	382,071 $15 Million
Q1 2021 May 11, 2021	BUY	$33.49 - $37.77 $1.97 Million - $2.23 Million	58,936 Added 10.98%	595,865 $21.6 Million
Q4 2020 Feb 16, 2021	SELL	$33.47 - $42.56 $68.3 Million - $86.9 Million	-2,041,072 Reduced 79.17%	536,929 $19.8 Million
Q3 2020 Nov 16, 2020	BUY	$31.75 - $37.25 $11.6 Million - $13.7 Million	366,809 Added 16.59%	2,578,001 $94.6 Million
Q2 2020 Aug 14, 2020	SELL	$30.12 - $36.54 $2.55 Million - $3.09 Million	-84,563 Reduced 3.68%	2,211,192 $72.3 Million
Q1 2020 May 13, 2020	BUY	$27.03 - $38.62 $44.4 Million - $63.5 Million	1,644,303 Added 252.41%	2,295,755 $74.9 Million
Q4 2019 Feb 11, 2020	BUY	$32.92 - $37.36 $19.8 Million - $22.4 Million	600,572 Added 1180.37%	651,452 $25.5 Million
Q3 2019 Nov 14, 2019	SELL	$32.49 - $42.13 $96.4 Million - $125 Million	-2,966,409 Reduced 98.31%	50,880 $1.83 Million
Q2 2019 Aug 13, 2019	SELL	$36.98 - $41.52 $74.5 Million - $83.7 Million	-2,015,326 Reduced 40.05%	3,017,289 $131 Million
Q1 2019 May 13, 2019	BUY	$37.5 - $41.2 $189 Million - $207 Million	5,032,615 New	5,032,615 $214 Million

Others Institutions Holding PFE

# of Institutions

3,253

Shares Held

3.72B

Call Options Held

73.5M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Easterly Investment Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Easterly Investment Partners LLC with notifications on news.

Account

Easterly Investment Partners LLC Pfizer Inc Transaction History